2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with tacrolimus in 2 studies
| Studies (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Trials (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Recent Studies (post-2010) (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demetris, AJ; Manez, R; Matsumoto, K; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Todo, S; Ye, Q | 1 |
| Asakura, T; Hayasi, J; Isogai, A; Kubota, S; Moriya, H; Shimizu, S; Takara, T; Watanabe, T; Yamaguchi, S | 1 |
2 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and tacrolimus
| Article | Year |
|---|---|
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition.
Topics: Animals; Blood Platelets; Complement C3; Cricetinae; Cyclophosphamide; Drug Therapy, Combination; Graft Survival; Hydroxamic Acids; Kidney Transplantation; Neutrophils; Premedication; Rats; Tacrolimus; Time Factors; Transplantation, Heterologous | 1995 |
Effects of the endothelin-1 receptor antagonist TAK-044 on pulmonary injury in discordant xenotransplantation.
Topics: Animals; Endothelin Receptor Antagonists; Guinea Pigs; Heart Transplantation; Hydroxamic Acids; Lung; Peptides, Cyclic; Rats; Receptor, Endothelin A; Tacrolimus; Transplantation, Heterologous | 2000 |